UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053735
Receipt number R000061321
Scientific Title Evaluation of the effect of sound stimulation on physiological functions
Date of disclosure of the study information 2024/03/01
Last modified on 2025/10/09 10:18:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the effect of sound stimulation on motion sickness (2)

Acronym

Evaluation of sound stimulation

Scientific Title

Evaluation of the effect of sound stimulation on physiological functions

Scientific Title:Acronym

Evaluation of sound stimulation

Region

Japan


Condition

Condition

Motion sickness

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims at evaluating the frequency-dependent effects of sound on motion sickness in humans.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Outcome Name: inner ear functions
Metric/method of measurement: Posturography, Vestibular evoked myogenic potential (VEMP), Distortion product otoacoustic emissions (DPOAEs), Pure-tone audiometry (PTA)
Timepoint: before and after interventions

Key secondary outcomes

Outcome Name: physiological functions and subjective symptoms
Metric/method of measurement: electrocardiogram, heart rate variability and questionnaires
Timepoint: before and after interventions


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

5

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Sound stimulation

Interventions/Control_2

Sound stimulation, linear shaking

Interventions/Control_3

Sound stimulation, driving simulator

Interventions/Control_4

Sound stimulation, car

Interventions/Control_5

Sound stimulation, rotation shaking

Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Healthy subjects without hearing and vestibular dysfunction such as vertigo and tinnitus are included in this study.

Key exclusion criteria

Subjects below 20 years old are excluded. Subjects who are older than 20 years old but do not have sufficient judgment or conscious mind, or are worried about the experiments are also excluded. In addition, subjects with contraindications to the medical devices used in this study are also excluded.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Masashi
Middle name
Last name Kato

Organization

Nagoya University Graduate School of Medicine

Division name

Occupational and Environmental Health

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2124

Email

kato.masashi.r6@f.mail.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Takumi
Middle name
Last name Kagawa

Organization

Nagoya University Graduate School of Medicine

Division name

Occupational and Environmental Health

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2124

Homepage URL


Email

meieisei@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Nagoya University School of Medicine

Address

65 Tsurumai-cho, Showa-ku, Nagoya

Tel

052-744-2479

Email

iga-shinsa@adm.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 02 Month 29 Day

Date of IRB

2016 Year 07 Month 15 Day

Anticipated trial start date

2024 Year 03 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We are recruiting participants through poster anouncement.


Management information

Registered date

2024 Year 02 Month 29 Day

Last modified on

2025 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061321